Yunnan Botanee Bio-Technology Group Co Ltd
Yunnan Botanee Bio-Technology Group Co.LTD, together with its subsidiaries, engages in the research, development, production, and sale of cosmetics in China and internationally. The company operates through Skin Care Products and Medical Instruments segments. It offers face creams, lotions, masks, and essences and lotions; and makeup products, including primers, powders, BB creams, and makeup rem… Read more
Yunnan Botanee Bio-Technology Group Co Ltd (300957) - Total Assets
Latest total assets as of September 2025: CN¥8.20 Billion CNY
Based on the latest financial reports, Yunnan Botanee Bio-Technology Group Co Ltd (300957) holds total assets worth CN¥8.20 Billion CNY as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Yunnan Botanee Bio-Technology Group Co Ltd - Total Assets Trend (2017–2024)
This chart illustrates how Yunnan Botanee Bio-Technology Group Co Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Yunnan Botanee Bio-Technology Group Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Yunnan Botanee Bio-Technology Group Co Ltd's total assets of CN¥8.20 Billion consist of 73.9% current assets and 26.1% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 21.8% |
| Accounts Receivable | CN¥1.08 Billion | 13.1% |
| Inventory | CN¥611.89 Million | 7.4% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥258.52 Million | 3.1% |
| Goodwill | CN¥323.05 Million | 3.9% |
Asset Composition Trend (2017–2024)
This chart illustrates how Yunnan Botanee Bio-Technology Group Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Yunnan Botanee Bio-Technology Group Co Ltd's current assets represent 73.9% of total assets in 2024, a decrease from 91.5% in 2017.
- Cash Position: Cash and equivalents constituted 21.8% of total assets in 2024, down from 52.4% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, an increase from 0.0% in 2017.
- Asset Diversification: The largest asset category is accounts receivable at 13.1% of total assets.
Yunnan Botanee Bio-Technology Group Co Ltd Competitors by Total Assets
Key competitors of Yunnan Botanee Bio-Technology Group Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Lonkey Industrial Co Ltd Guangzhou
SHE:000523
|
China | CN¥3.66 Billion |
|
Taiyen Biotech Co Ltd
TW:1737
|
Taiwan | NT$8.26 Billion |
|
Tianjin Yiyi Hygiene Products Co Ltd
SHE:001206
|
China | CN¥2.20 Billion |
|
Hunan Resun Co Ltd
SHE:001218
|
China | CN¥3.08 Billion |
|
Dencare (Chongqing) Oral Care Co. Ltd. A
SHE:001328
|
China | CN¥1.90 Billion |
|
Qingdao Kingking Applied Chemistry Co Ltd
SHE:002094
|
China | CN¥3.19 Billion |
|
C&S Paper Co Ltd
SHE:002511
|
China | CN¥9.17 Billion |
|
Anhui Deli Household Glass Co Ltd
SHE:002571
|
China | CN¥3.08 Billion |
Yunnan Botanee Bio-Technology Group Co Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Yunnan Botanee Bio-Technology Group Co Ltd generates 0.69x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Yunnan Botanee Bio-Technology Group Co Ltd generates $6.06 in net profit.
Yunnan Botanee Bio-Technology Group Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.64 | 4.60 | 3.56 |
| Quick Ratio | 3.14 | 3.85 | 2.91 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥4.15 Billion | CN¥ 4.36 Billion | CN¥ 999.98 Million |
Yunnan Botanee Bio-Technology Group Co Ltd - Advanced Valuation Insights
This section examines the relationship between Yunnan Botanee Bio-Technology Group Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.10 |
| Latest Market Cap to Assets Ratio | 0.12 |
| Asset Growth Rate (YoY) | 10.6% |
| Total Assets | CN¥8.30 Billion |
| Market Capitalization | $969.48 Million USD |
Valuation Analysis
Below Book Valuation: The market values Yunnan Botanee Bio-Technology Group Co Ltd's assets below their book value (0.12 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Yunnan Botanee Bio-Technology Group Co Ltd's assets grew by 10.6% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Yunnan Botanee Bio-Technology Group Co Ltd (2017–2024)
The table below shows the annual total assets of Yunnan Botanee Bio-Technology Group Co Ltd from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥8.30 Billion | +10.61% |
| 2023-12-31 | CN¥7.51 Billion | +11.73% |
| 2022-12-31 | CN¥6.72 Billion | +15.59% |
| 2021-12-31 | CN¥5.81 Billion | +262.86% |
| 2020-12-31 | CN¥1.60 Billion | +47.80% |
| 2019-12-31 | CN¥1.08 Billion | +41.87% |
| 2018-12-31 | CN¥763.97 Million | +52.23% |
| 2017-12-31 | CN¥501.84 Million | -- |